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Mediastinal lymphadenopathy and auto-antibodies are clinical phenomena during
ischemic heart failure pointing to an autoimmune response against the heart. T and
B cells have been convincingly demonstrated to be activated after myocardial infarction,
a prerequisite for the generation of mature auto-antibodies. Yet, little is known about
the immunoglobulin isotype repertoire thus pathological potential of anti-heart autoantibodies during heart failure. We obtained human myocardial tissue from ischemic
heart failure patients and induced experimental MI in rats. We found that anti-heart
autoimmunity persists during heart failure. Rat mediastinal lymph nodes are enlarged
and contain active secondary follicles with mature isotype-switched IgG2a B cells.
Mature IgG2a auto-antibodies specific for cardiac antigens are present in rat heart failure
serum, and IgG and complement C3 deposits are evident in heart failure tissue of both
rats and human patients. Previously established myocardial inflammation, and the herein
provided proof of B cell maturation in lymph nodes and myocardial deposition of mature
auto-antibodies, provide all the hallmark signs of an established autoimmune response
in chronic heart failure.
Keywords: chronic heart failure, myocardial infarction, autoimmunity, auto-antibodies, anti-heart, adaptive
immune system

INTRODUCTION
Chronic heart failure (CHF) describes a pathological condition in which the heart is unable
to pump enough blood to meet the metabolic demands of the body. It is the final outcome
of a range of disorders including ischemic heart disease following myocardial infarction (MI)
(Torabi et al., 2008), and a major public health problem affecting 26 million people worldwide
(Ziaeian and Fonarow, 2016).
The immune system has been implicated in the immediate response to MI, and is crucial for
quick tissue repair (Nahrendorf and Swirski, 2016). However, the post-MI immune response does
not cease once acute inflammation has been resolved, and excessive activation of endogenous repair
mechanisms may lead to ongoing inflammation, fibrosis, and sustained tissue damage (Sattler
et al., 2017). Cardiac self-antigens released from necrotic cardiomyocytes in a highly inflammatory
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GRAPHICAL ABSTRACT | The adaptive anti-heart immune response in CHF. A myocardial infarction initiates an adaptive immune response with activation of the
heart draining mediastinal lymph nodes, formation of secondary follicles and B cell maturation with production of mature self-reactive auto-antibodies which may
subsequently induce cardiomyocyte dysfunction and death.

nodes to facilitate B cell affinity maturation and class switching to
mature IgG isotypes, which convey a range of effector functions
(Hamel et al., 2012). Information on the auto-antibody isotypes
in post-MI and CHF patients is limited, and further research
may yield fundamental insights into pathological effects of autoantibodies present in these patients.
In the present study, we document an active adaptive immune
response against the heart with the presence of mature classswitched anti-heart auto-antibodies in the serum as well as
deposited in the myocardium in both rats with experimental
heart failure and human heart failure patients. We also detected
myocardial deposition of complement, which suggests immunecomplex mediated pathology.

environment also activate and trigger myocardial infiltration of
autoreactive B and T cells of the adaptive immune system (VardaBloom et al., 2000; Yan et al., 2013; Zouggari et al., 2013; Tang
et al., 2019). These can be long-lived and may cause sustained
damage to the myocardium.
The presence of anti-cardiac auto-antibodies in post-MI
serum is a well-known clinical phenomenon (Kaya et al.,
2012). Post-MI Dressler syndrome was first described in
the 50s and is now recognized as an adaptive immune
response against myocardial proteins (Spodick, 2004). However,
besides rare cases of clinically obvious extreme manifestations,
persistent subclinical auto-reactivity can cause ongoing damage
to previously healthy myocardial tissue, which may increase
the risk of adverse remodeling and heart failure. Notably,
enlargement of the mediastinal lymph nodes draining the heart
has been observed during heart failure, but was explained by
hemodynamic mechanisms related to cardiac decompensation
(Ngom et al., 2001; Pastis et al., 2011). Activated B cells generate
tissue-specific auto-antibodies and pro-inflammatory cytokines,
which can directly contribute to cardiac dysfunction. Activated
B and T cells interact in germinal centers of draining lymph
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MATERIALS AND METHODS
MI Surgery
All animal procedures were approved by the Imperial College
Governance Board for Animal Research and in accordance
with the United Kingdom Home Office Animals (Scientific
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Procedures) Act 1986 and Directive 2010/63/EU of the European
Parliament on the protection of animals used for scientific
purposes. 30 Sprague Dawley (all male, 250 to 350 g) were
obtained from Charles River Laboratories, United Kingdom. MI
was induced by LAD ligation as described previously (Mawad
et al., 2016). Anesthesia was induced with 5% isoflurane and
maintained at 2% after intubation. Perioperative analgesic regime
included buprenorphine (0.05 mg/kg) and Rimadyl (5 mg/kg),
Baytril (5 mg/kg), and sub-cutaneous 1 ml of 0.9% saline for
hydration. After left parasternal incision, thoracotomy through
the fourth intercostal space and removal of the pericardium,
ligation of the LAD was performed 1–2 mm distal to the inferior
border of the left atrium using a 7–0 Prolene suture. The
thoracotomy, chest wall and the skin were closed using 4–0 Vicryl
sutures. Daily doses of Rimadyl were administered for at least
48 h after surgery for post-operative analgesia.

qPCR
Cells were taken up in TRIzolTM (both Gibco, Thermo
Fisher Scientific, Dartford, United Kingdom) and RNA isolation
was performed using phenol-chloroform extraction. RNA
concentration and purity were determined by using a NanoDrop
spectrophotometer (ND-8000-GL, Thermo Fisher Scientific,
Rochford, United Kingdom). RNA cleanup was performed
using the RNeasy Mini Kit (Qiagen, Hilden, Germany)
according to manufacturer’s instructions and RNA concentration
was adjusted to 500 ng/µl. cDNA was synthesized using
the RT2 first strand kit. qPCR was performed using RT2
SYBR Green qPCR Mastermix and the Rat T-Cell and
B-Cell Activation RT2 Profiler qPCR array (all Qiagen,
Hilden, Germany), according to manufacturer’s protocols
using a RealPlex2 Eppendorf Mastercycler . Threshold cycle
(Ct ) values of the target genes were normalized to the
experimental control. Data analysis was performed using the
2−11Ct method.
R

R

Human Tissue Samples
All work was carried out under the guidelines of the Human
Tissue Act 2004 and conform to the principles outlined in
the Declaration of Helsinki. Only fully anonymized tissue and
corresponding clinical data was available to researchers. Human
left ventricular tissue sections were obtained from hearts of endstage heart failure patients removed during transplant surgery
(REC: 09/H0504/104+5; Biobank approval number: NP00106-2015). Control samples were prepared from organ donor
hearts assessed to be unsuitable for donation (REC: 16/LO/1568).
Informed consent was obtained from each patient involved in this
study or next of kin in case of donors. Patient characteristics:
HF due to ischemic heart disease; 2 females (45, 60 years),
5 males (57–67 years); HF due to myocarditis; 2 females
(20, 28 years), 1 male (51 years); donors; 3 females (17, 38,
50 years), 2 males (48, 39 years). CMR images were acquired
on a 1.5 T scanner to exemplify mediastinal lymphadenopathy
in the context of ischemic cardiomyopathy with a 2-month
old transmural myocardial infarction in the circumflex artery
territory and mild LV systolic dysfunction.

Immunofluorescence Staining
For analysis of auto-antibody binding, healthy rat hearts were
frozen in OCT (Sigma-Aldrich, Gillingham, United Kingdom)
and cut into 5 µm sections. Control, 2- and 16-weeks
post-MI sera were used as primary antibodies in 1:100
dilution and incubated overnight at 4◦ C. Sections were
washed 3 times and a secondary anti-rat IgG AlexaFluor
488 antibody (BioLegend, London, United Kingdom)
was used for detection. Wheat germ agglutinin (WGA)594 (Invitrogen, Thermo Fisher Scientific,
AlexaFluor
Rochford, United Kingdom) was used as membrane
counterstain. Sections were mounted with DAPI-containing
mounting medium (Vectashield, Vector Laboratories,
Peterborough, United Kingdom). For detection of IgG2a+
cells in mediastinal lymph nodes, frozen LN sections were
stained with Alexa Fluor 488 Goat anti-rat IgG and
Alexa Fluor 647 anti-rat IgM (both BioLegend, London,
United Kingdom). IgG and complement C3 deposits in
rat and human CHF tissue were detected using; Alexa
Fluor 488 goat anti-rat IgG and rabbit anti-rat C3 with
Alexa Fluor 488 goat anti-rat IgG (all BioLegend, London,
United Kingdom), rat anti-human IgG with Alexa Fluor
488-anti-rat IgG and mouse anti-human C3 (Abcam,
Cambridge, United Kingdom) with Alexa Fluor 488 Goat
anti-mouse IgG. Sections were mounted using DAPI mounting
medium (Vectashield, Vector Laboratories, Peterborough,
United Kingdom). Mean fluorescent intensity (MFI) of IgG
and C3 deposition was quantified using FIJI/ImageJ (Schneider
et al., 2012). Obtained MFI of fully stained sections were
normalized against corresponding control sections of the
same animal to correct for variations in cardiomyocyte
autofluorescence.
R

R

R

R

R

R

Adult Rat Cardiomyocyte Isolation

R

Euthanasia was performed by cervical dislocation after induction
of terminal anesthesia using 5% isoflurane. Hearts were excised,
cannulated via the aorta and perfused with Krebs-Henseleit
buffer (KH) at 37◦ C using a Langendorff apparatus. After
blood was cleared from the coronary circulation, KH buffer
was switched to a low calcium (LoCa2+) buffer to stop
contraction. A solution of 1 mg/ml Collagenase II and 0.6 mg/ml
Hyaluronidase (C+H) in enzyme buffer was perfused into the
heart for 10 min after which it was minced in fresh C+H
buffer. Heart samples were disrupted mechanically at 35◦ C
for 5 min followed by further 30 min and the supernatant
filtered through gauze. Filtrates were centrifuged for 1 min
at 700 rpm and cardiomyocyte pellets re-suspended. Isolated
primary adult cardiomyocytes were cultured in modified M199
medium (Thermo Fisher Scientific, Rochford, United Kingdom)
and treated with post-MI sera at a dilution of 1:10 for 24 and 48 h.
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ELISA
ELISA plates (SpectraMax Paradigm Molecular-Devices,
United Kingdom) were coated with 50 µl per well of 4 µg/µl
pig full heart lysate (Novus Biologicals, Bio-Techne, Abingdon,
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Blood was visible in the medullary sinuses of the week
2 post-MI lymph nodes, indicating that they drained an
area of hemorrhage (Figure 1B), which is in line with
the myocardial damage induced by LAD. Quantification of
lymph node size, total number of follicles and the percentage
of follicles with GC confirmed an activated state at week
16, albeit decreased compared to week 2 (Figure 1C).
Transcription of genes involved in B cell development and
activation, including Rag1, Cd20(MS4a1), Cd81 was upregulated
in the spleen 2 weeks post-MI, and some were still elevated
over baseline at CHF stage (Figure 1D). Recombination
activating gene (Rag1) was elevated most prominently in
both week 2 and week 16, consistent with its role in
B cell development and Ig formation. Rag expression is
also upregulated in antigen-activated early memory B cells
during autoimmune responses (Wang and Diamond, 2008).
Sustained upregulation of Il4 and the Th2-associated chemokine
receptor Ccr3 together with an increase in Cd40 (Tnfrsf5)
but a downregulation of Cd40lg (Tnfsf5) may provide an
environment blocking apoptotic cell death and inducing
sustained B cell growth and differentiation (Nakanishi et al., 1996;
Toellner, 2014).

United Kingdom) recombinant pig myosin (Sigma-Aldrich,
Gillingham, United Kingdom) or mouse troponin I (Abcam,
Cambridge, United Kingdom) diluted in PBS overnight at 4◦ C.
Plates were washed 3 times for 5 min each with 200 µl per
well of ELISA washing buffer. Then, 50 µl of rat serum per
well was added in either 1:10 or 1:100 dilutions for overnight
incubation at 4◦ C. Detection reagents were anti-rat IgG-HRP
or IgG1/2a/2b/2c-Biotin combined with Streptavidin-HRP (all
BioLegend, London, United Kingdom).
For relative quantification of antibody isotypes in the serum,
a Rapid Antibody Isotyping Assay Kit, rat (Thermo Fisher
Scientific, Rochford, United Kingdom) was used according to
the manufacturer’s instructions using previously determined
serum dilutions (Hasham et al., 2017). For all ELISA assays,
detection steps were performed using a TMB ELISA buffer kit
(Peprotech, London, United Kingdom) as per manufacturer’s
instructions. An ELISA plate reader (SpectraMax Paradigm
Molecular-Devices, United Kingdom) was used to measure light
absorbance at 450 nm for the HRP product and 570 nm for the
plastic background.

Statistical Analysis
Statistical analysis was performed using SPSS or GraphPad
Prism 6 and data were presented as mean ± SEM. 2-group
comparisons were analyzed using 1- or 2-tailed unpaired
Student’s t-tests. Comparison between multiple groups
was performed using ANOVA with Dunnett’s multiple
comparisons post hoc test to obtain multiplicity-adjusted
p-values. Datasets of n > 10 that failed the D’Agostino
and Pearson omnibus normality test were analyzed
using non-parametric Kruskal-Wallis test with Dunn’s
multiple comparisons post hoc test to obtain multiplicityadjusted p-values. Differences were considered significant at
p < 0.05.

The CHF Antibody Repertoire Shifts
Toward Mature Class-Switched Isotypes
The presence of active GC in heart-draining lymph nodes during
CHF marks an ongoing B cell maturation process. To assess
maturity of the CHF antibody repertoire, we characterized the
isotype composition of the local and systemic antibody repertoire
in response to MI and their potential for pathological effects.
Serum was collected 2 and 16 weeks post-MI and analyzed by
ELISA for relative concentrations of immunoglobulin (Ig) light
chains (IgKappa and IgLambda) and heavy chains (immature
IgM, mature class-switched IgG1, IgG2a–c). A dramatic increase
in overall antibody levels was evident (Figure 2A). IgM levels
were comparable to baseline levels at both week 2 and week
16 (Figure 2B), likely due to baseline levels of natural IgM
(Haas et al., 2010) or a missed early peak. Mature IgG isotypes
on the other hand were increased, most prominently IgG2a
(Figure 2C). This was accompanied by a marked increase
of IgG2a+ cells in the mediastinal lymph nodes, indicating
heart specificity of mature class-switched autoreactive B cells
at CHF stage (Figure 2D). As expected for mature classswitched B cells (Zhang et al., 2013), IgG2a+ cells were detected
within and around the GC. Another striking accumulation
was observed in the subcapsular sinuses, where mature B
cells have previously been shown to interact with antigen
(Carrasco and Batista, 2007; Phan et al., 2007) thus putting
them in the correct position to quickly react to cardiac antigen
drained from the heart.

RESULTS
Persistent Reactivity of Heart-Draining
Lymph Nodes During CHF
An MI is a potent trigger for an acute innate immune reaction,
including early infiltration of neutrophils and macrophages
(Nahrendorf and Swirski, 2016). Evidence is accumulating that
T and B cells are also activated within a week post-MI (Kaya
et al., 2012). Importantly, as described previously (Slanetz
et al., 1998; Pastis et al., 2011), mediastinal lymphadenopathy
is a common finding in patients with heart failure due to
ischemic heart disease (Figure 1A). To further investigate
if this phenomenon is indicative of the activation of the
adaptive immune system in CHF, myocardial infarction was
induced in male Sprague Dawley rats by surgical ligation of
the left anterior descending (LAD) coronary artery. Heartdraining mediastinal lymph nodes were isolated at week
2 and week 16 after infarct surgery and analyzed for
signs of reactivity. They showed distinct lymphoid follicles
containing active germinal centers (GC) acutely post-MI (2
weeks) as well as at chronic stage (16 weeks) post-MI.

Frontiers in Cell and Developmental Biology | www.frontiersin.org

CHF Serum Contains Mature Anti-heart
Auto-Reactive Antibodies
While the degree of overall increase in total antibody
concentration and elevation of potentially pathological isotypes
such as IgG2a in the periphery and the draining lymph nodes
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FIGURE 1 | Persistent activation of heart-draining lymph nodes at CHF stage after infarction. (A) Example of 1.5 T cardiac MRI images of mediastinal
lymphadenopathy in a patient with ischemic cardiomyopathy 2 months after transmural myocardial infarction in the circumflex artery territory. (a) 3-chamber cine view
of the heart before gadolinium injection showing the left ventricle (LV), left atrium (LA) and aorta (Ao). (b) 3-chamber view of the heart showing late gadolinium
enhancement (LGE) and transmural myocardial infarction in the infero-lateral wall of the LV. (c,d) Cardiac MRI transverse (c) and coronal (d) HASTE sequences
showing mediastinal lymphadenopathy (arrows) in a patient with ischemic cardiomyopathy. (B–D) Myocardial infarction was induced by surgical ligation of the LAD.
Mediastinal (heart draining) lymph nodes were obtained from healthy rats (ctrl), 2 weeks (acute post-MI) and 16 weeks (CHF stage) post-MI. (B) Histology (H&E)
sections of representative lymph nodes. Post-MI rats show distinct lymphoid follicles containing active germinal centers (black arrows). Hemorrhage (gray arrow) is
present in the medullary sinuses of the week 2 post-MI lymph nodes, indicating that they drain an area of hemorrhage. (C) Lymph node size and quantification of the
total number of follicles and the percent of follicles with germinal centers. Data are expressed as mean +/–SEM for n = 3 (ctrl) and 4 (week 2, 16) animals, *p < 0.05,
**p < 0.005, ***p < 0.001 (ANOVA with Dunnett’s multiple comparisons post hoc test). (D) qPCR Array testing a range of genes involved in B cell activation. Bars
represent expression change over baseline, with healthy baseline values set to 0. Experiment performed in triplicates on 3 pooled spleens of ctrl (healthy baseline),
week 2 and week 16 post-MI rats.

is striking in itself, CHF serum also contained auto-antibodies
specific to cardiac protein. An ELISA assay using post-MI serum
against coated healthy heart lysate showed a progressive increase
in the levels of anti-heart IgG auto-antibodies (Figure 3A).
Characterization of the heart-specific auto-antibody population
confirmed that it also contains mature class-switched IgG1,
IgG2a, and IgG2b isotype antibodies (Figure 3B). Although
individuals show variable levels of IgG2a and IgG2b antiheart auto-antibodies at CHF stage, elevation over baseline is
evident in all animals.
A variety of major cardiac proteins, including cardiac
myosin and troponin I, are targeted by auto-antibodies post

Frontiers in Cell and Developmental Biology | www.frontiersin.org

MI (Kaya et al., 2012). To assess binding of auto-antibodies
to cardiac structures, CHF and control sera were used to
stain frozen sections of healthy rat hearts. Strong staining was
observed when using CHF serum, with a pattern resembling
cardiomyocyte striations. This confirms auto-antibodies specific
to the cardiomyocyte contractile apparatus are present in
CHF serum (Figure 3C). ELISA assay against recombinant
myosin and troponin I confirm the presence of mature
IgG auto-antibodies against the cardiomyocyte contractile
machinery in rat CHF serum (Figures 3D,E). Notably, while
all CHF rats harbor anti-myosin antibodies, anti-troponin
antibodies are only found in 60% of CHF animals, indicating

5

August 2020 | Volume 8 | Article 695

Sintou et al.

Autoimmunity in Chronic Heart Failure

FIGURE 2 | Levels of IgG2a antibodies in the circulation and IgG2a+ cells in the heart-draining lymph nodes are elevated during CHF. Myocardial infarction was
induced by surgical ligation of the LAD. Serum was collected 2 weeks (acute post-MI) and 16 weeks (chronic heart failure stage) post-MI and analyzed by ELISA for
relative concentration of (A) immunoglobulin (Ig) light chains (IgKappa and IgLambda) and (B,C) heavy chains (immature IgM (B), and mature class-switched IgG1,
IgG2a, b and c (C). n = 5 (ctrl, week 2) and 11 (week 16) / group (D) Immunofluorescence staining of mediastinal lymph nodes with anti-rat IgM (green) and anti-rat
IgG2a (red). n = 4 (ctrl, week 2) and 6 (week 16) / group, Data are expressed as mean +/–SEM, **p < 0.001, ***p < 0.0001 (ANOVA with Dunnett’s multiple
comparisons post hoc test).

stronger immunogenicity of myosin in the post-MI process of
autoimmune induction.

Importantly, IgG deposition was detected in frozen heart tissue
obtained from CHF rats, confirming anti-heart auto-antibodies
can reach their cardiac antigen and deposit within the tissue
in vivo. Besides a significant amount of IgG in severely
damaged and scarred tissue areas, we also observed deposition in
apparently healthy areas of rat CHF hearts (Figure 4A). Immunecomplex formation between autoreactive IgG and complement
C3 and subsequent cytotoxicity is a prominent pathological

Immunoglobulin G and Complement C3
Deposit in Myocardial Tissue During CHF
The ability to reach and bind to antigenic epitopes in vivo
is crucial for the pathological function of auto-antibodies.

Frontiers in Cell and Developmental Biology | www.frontiersin.org
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FIGURE 3 | CHF serum contains anti-heart auto-reactive antibodies of mature class-switched isotypes. Myocardial infarction was induced by surgical ligation of the
LAD. Serum was collected 2 weeks (acute post-MI) and 16 weeks (chronic heart failure stage) post-MI and analyzed by ELISA and immunofluorescence microscopy
for the presence of heart specific auto-antibodies. (A,B) ELISA using post-MI serum against rat heart lysate (protein fraction) showing a progressive increase in the
levels of (A) total IgG (n = 5 / group) and (B) IgG1, IgG2a, and IgG2b isotype auto-antibodies reactive against the heart (n = 5 (ctrl, week 2) and 10 (week 16) /
group). (C) Representative images and quantification of immunofluorescence staining using post-MI serum on frozen sections of healthy rat hearts to assess binding
of auto-antibodies to cardiac structures. Staining intensity was quantified by measuring mean fluorescence intensity (MFI) using FIJI/ImageJ. (D,E) ELISA using
post-MI serum against recombinant pig myosin (D) and mouse troponin I (E). Dotted line represents threshold for calculation of % of positive animals. Data are
expressed as mean +/–SEM, *p < 0.05, **p < 0.001, ***p < 0.0001 [ANOVA with Dunnett’s multiple comparisons post hoc test (A–C), one-tailed Student’s t-test
with Welch correction (D)].

mechanism in auto-immune-mediated tissue destruction. In line
with this, we also detected complement C3 in rat CHF tissue
(Figure 4B).
Notably, IgG and complement C3 were also detected in human
end-stage HF tissue (Figures 4C,D). Left ventricular tissue was
obtained from end-stage HF patients during transplant surgery,
and control samples were obtained from organ donor hearts
deemed unsuitable for transplantation. Donors were 3 female
and 2 male individuals aged 17 to 50 years. HF patients were 2

Frontiers in Cell and Developmental Biology | www.frontiersin.org

female (45 and 60 years) and 5 male (57–67 years) individuals
with end stage HF due to ischemic heart disease (IHD) after
MI. We also included 3 patients (2 females of 20 and 28 years
and 1 male of 38) with heart failure due to prior myocarditis
as positive controls for confirmation of the presence of IgG and
C3 in heart disease with established immunological etiology. We
found IgG deposition in all besides 1 IHD HF samples (86%)
compared to only 1 of 5 donor samples (20%) (Figure 4C).
Complement C3 followed the same pattern although staining
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In addition to local inflammation, the presence of auto-antibodies
against major cardiac proteins (Kaya et al., 2012) as well as
mediastinal lymphadenopathy are recognized clinical findings
in patients with heart failure (Slanetz et al., 1998; Joffre
et al., 2004; Pastis et al., 2011). Importantly, all of these are
hallmark signs of other prototype autoimmune diseases including
rheumatoid arthritis (Bouta et al., 2015) type 1 diabetes (Leeth
et al., 2016) and multiple sclerosis (Pröbstel et al., 2015).
In addition, the role of the cardiac lymphatics in ischemic
heart disease and heart failure has recently recieved attention
(Henri et al., 2016; Brakenhielm and Alitalo, 2019). Yet while
we are starting to appreciate that anti-heart autoantibodies as
well as cardiac lymphatics may have a role in heart failure,
mediastinal lymphadenopathy remains unexplored. The reasons
behind this phenomenon are speculative and have previously
been explained by hemodynamic mechanisms related to cardiac
decompensation and increased generalized edema in the lungs

intensity was overall lower (Figure 4D). Both IgG and C3 were
found in all myocarditis HF samples. Notably, the pattern of IgG
and C3 deposition was consistent between IHD and myocarditis
HF tissue. While strongest staining was observed in perivascular
areas, interstitial staining between cardiomyocytes and along
cardiomyocyte membranes was also evident.
The above confirms the ability of anti-heart auto-antibodies
during late stages of heart failure to cause ongoing tissue injury,
not only in already damaged tissue but also in apparently healthy
areas of the heart in both rodents and humans.

DISCUSSION
Heart failure affects 26 million people worldwide (Ziaeian
and Fonarow, 2016) and myocardial inflammation plays an
important role in local tissue destruction (Frangogiannis, 2012).

FIGURE 4 | Continued

Frontiers in Cell and Developmental Biology | www.frontiersin.org
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FIGURE 4 | Immunoglobulin G and complement C3 deposit in rodent and human CHF heart tissue. MI was induced by surgical ligation of the LAD and heart tissue
was collected during CHF after 16 weeks of MI. Human left ventricular tissue sections were obtained from end-stage heart failure patients during transplant surgery.
Control samples for comparison were obtained from organ donor hearts assessed to be unsuitable for donation. Representative images and corresponding
quantification (mean fluorescence intensity) of immunofluorescence staining against IgG and complement C3 on frozen sections of CHF rat hearts (A,B) and
end-stage human HF heart (C,D) to assess in vivo IgG and C3 deposition on cardiac structures, respectively. rat n = 3 (control), 5 (CHF); human n = 5 (donors), 7
(CHF), 3 (myocarditis). Staining intensity was quantified by measuring mean fluorescence intensity (MFI) using FIJI/ImageJ. Data are expressed as mean +/–SEM,
*p < 0.05, ***p < 0.001 (one-tailed Student’s t-test with Welch correction).

also affecting the lymph nodes (Ngom et al., 2001; Joffre et al.,
2004; Pastis et al., 2011).
In this study, we document an active autoimmune state
against the heart during CHF using a rat heart failure model

Frontiers in Cell and Developmental Biology | www.frontiersin.org

(Graphical Abstract). Rodent mediastinal lymph nodes contain a
high number of IgG2a positive cells, representing mature B cells
that class-switched to IgG2a. Importantly, in vivo deposition of
IgG auto-antibodies and complement C3 in CHF heart tissue
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long-term benefits. Importantly, identification of CHF as another
member of the expanding family of immune-mediated diseases
thus opens the door for new experimental, diagnostic and
therapeutic approaches.

in both rodents and human patients confirms that these autoantibodies reach cardiac tissue in vivo and will be able to
damage previously unaffected areas of the myocardium. Upon
activation, immature B cells undergo either clonal expansion
for immediate antibody production or germinal center reactions
in the lymph nodes. The germinal center reaction including
somatic hyper-mutation and class-switch recombination creates
high affinity antibodies with variable Fc portions (Hamel et al.,
2012). The Fc portion of antibodies is of particular importance
as it conveys their effector functions, which include (a) direct
induction of cell death by receptor cross-linkage or blockade
of receptor-ligand interactions, (b) recruitment of effector
cells for antibody-dependent cell-mediated cytotoxicity (ADCC),
or (c) antibody-dependent cellular phagocytosis (ADCP) by
engagement of activating Fcγ receptors (FcγR) or complementdependent cytotoxicity (CDC) (Lu et al., 2018). Depending
on specificity and isotype, anti-cardiac auto-antibodies in CHF
can therefore result in cardiac injury in a variety of ways (Li
et al., 2006; Ludwig et al., 2017). Most notably, antibodies of
IgG2 isotype including IgG2a and IgG2b play well established
pathogenic roles in autoimmune diseases such as systemic
lupus erythematosus (SLE) (Ehlers et al., 2006). As we reported
previously in a rodent SLE model, anti-cardiac antibodies of
IgG2a and IgG2b isotype are present in circulation and deposit
in the hearts (Hasham et al., 2017). IgG auto-antibodies activate
the complement cascade, which culminates in formation of
the cytolytic membrane attack complex (MAC) comprising of
complement C5b-9. The MAC forms a trans-membrane pore
leading to necrotic death of the target cell (Bohana-Kashtan
et al., 2004). At sub-lytic concentrations, MAC can induce caspase
activation and apoptosis (Nauta et al., 2002). Complement is
accepted as a mediator of additional damage during acute MI
and after reperfusion (Yasojima et al., 1998; Griselli et al., 1999),
and sub-lytic activity has been implicated in the development
of dilated cardiomyopathy. C5b-9 correlates with myocardial
immunoglobulin deposition and expression of TNF-α. In vitro,
C5b-9 attack on cardiomyocytes induces nuclear factor (NF)κB activation as well as transcription, synthesis, and secretion
of TNF-α by the cardiomyocytes themselves (Zwaka et al.,
2002). NF-κB activation and TNF-α both induce cardiomyocyte
hypertrophy (Sun et al., 2007; Hamid et al., 2011) in vitro,
and the presence of immune cells able to respond to autoantibody deposition in vivo will further increase the number of
pathological pathways that contribute to CHF.
In summary, we show that long after the initially ischemic
trigger event, CHF serum still contains active auto-antibodies
against the heart with potent pathological functional isotypes.
This confirms that post-MI immune auto-reactivity is indeed
likely to be a crucial contributing factor to adverse remodeling
in remote areas of the myocardium. This offers new avenues
for therapeutic intervention in heart failure. A large number
of clinical trials have attempted to improve post-MI outcome
by early immunomodulation, with a strong focus on acute
inflammation and short term readouts (Panahi et al., 2018;
Ridker et al., 2018). However, immunomodulatory strategies
targeting the adaptive immune system with the aim to restore
immunological tolerance to the heart may have more potent
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Study Limitations
In this study, we interpreted the presence of mature
class-switched auto-antibodies against cardiac antigens as
representative of anti-heart autoimmunity. We did not quantify
the numbers of infiltrating B and T cells as this provides little
information regarding a potential pathological role. In addition,
very convincing prior data on post-MI B and T cell numbers
exist for both mouse and humans (Yan et al., 2013; Zouggari
et al., 2013; Saxena et al., 2014; Rieckmann et al., 2019; Tang
et al., 2019) and it is anticipated that the rat follows a comparable
trajectory of post-MI myocardial infiltration.
Cellular assays to characterize the phenotype and function of
heart-infiltrating B and T cell populations will be informative.
These are currently restricted by the lack of flow cytometry
antibody reagents specific to rat B and T cell activation markers
but may be possible in the near future. The current study provides
direct evidence of B cell activation as shown by the existence
of secondary follicles in the mediastinal lymph nodes, activation
markers in qPCR, and most importantly IgG2 staining in the
lymph nodes. Also, presence of IgG autoantibodies requires the
full cascade of T cell-B cell activation upstream.
IgG and Complement C3 deposition in the myocardium
indicate immunocomplex-mediated tissue pathology. However,
additional mechanistic studies are needed to prove a direct
pathological effect of anti-heart autoantibodies in CHF.
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